Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
46.84 EUR | 0.00% | 0.00% | 0.00% |
04-30 | COVESTRO : Barclays maintains a Buy rating | ZD |
04-30 | Global markets live: Adidas, Mercedes, McDonalds, Eli Lilly, PayPal, MicroStrategy, Tesla... |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.78 for the current period. Therefore, the company is undervalued.
Weaknesses
- The company sustains low margins.
- With an expected P/E ratio at 45.29 and 16.31 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
0.00% | 9.47B | - | ||
+4.36% | 40.24B | B- | ||
-19.34% | 22.02B | B- | ||
-13.51% | 13.39B | B- | ||
-10.91% | 9.97B | B+ | ||
+5.92% | 7.7B | C+ | ||
+12.15% | 7B | C+ | ||
-26.77% | 5.56B | C | ||
-29.83% | 3.28B | B+ | ||
-23.47% | 3.15B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 1COV Stock
- 1COV Stock
- Ratings Covestro